newsfilter
← Latest News
Business Wire·

Gilead Sciences Announces Completion of Acquisition of CymaBay

Acquisition Reinforces Gilead's Leadership in Developing Innovative Therapies For Challenging Liver Diseases Gilead Sciences, Inc. (NASDAQ:GILD) today announced the completion of the previously announced transaction